"Venlafaxine": reviews, ntuziaka maka ojiji, analogs

N'oge, ọtụtụ ndị na-ewekarị nchegbu na ịda mbà n'obi, nke ọ bụghị nanị egbochi kwesịrị ndụ, kamakwa imetụta ahụ ike. A siri ike mmadụ pụrụ ịnagide nsogbu na ihe ịma aka. Ụfọdụ ida, na ha na-ada n'ime a ịda mbà n'obi na-achọ ọkachamara aka ọkachamara na ọgwụgwọ. Otu n'ime ihe ndị kasị na-ewu ewu antidepressant bụ a ọgwụ "venlafaxine". Ntuziaka, comments - niile nke ozi a kwesịrị ịgụ tupu ịmalite usoro ọgwụgwọ.

mmetụta nke ọgwụ

Ukwu na-ezo aka a ìgwè nke ọgwụ na-kenyere iji kpochapụ doldrums. Ọgwụ nwere a pụrụ iche chemical mejupụtara, nke bụ yiri ọzọ dị iche iche nke mgbochi depressants. The ọgwụ nwere ihe abụọ ifịk enantiomer racemic iche-iche.

Inweta n'ime, isi mgwa enhances ọgụgụ akwara mbufe ozi na-eme CNS. Ọnụ na metabolite nkwadebe ha nwere ike inhibitors nke serotonin na nọrepinefrini na dopamine reuptake ala akwara ozi na-ebelata beta adrenergic omume.

Ọgwụ, na-echefu n'ime, ngwa ngwa etinye obi gị dum na afo. Mgbe a otu ngwa dose ruo 150 mg nke kacha mmetụta nke ọgwụ na plasma bụ imezu mgbe awa atọ. First-ngafe imeju metabolism na-doro ike pụtara "venlafaxine". Nyocha nke dọkịta na-egosi na ọgwụ nwere ike ná mmalite nke usoro ọgwụgwọ na-egosi a eti utịp.

Egosi na contraindications

The ọgwụ na-eji na dara ya mbà na-ekwu. E nwere contraindications. Nke a na-agụnye:

• gbasara akụrụ odida;
• imeju daa ọrịa;
• afọ 18 afọ;
• hypersensitivity na-arụsi ọrụ ike akụrụngwa;
• ime;
• lactation.

onunu ogwu

Pụtara zubere maka onu ochichi. Early ọgwụgwọ a na-atụ aro na-aṅụ 75 mg abụọ kewara doses (ụtụtụ na mgbede). Ọ bụrụ na nti Ọnọdụ nke ọrịa a hụrụ, mgbe a izu ole na ole na onunu ogwu nwere ike mụbara 150 mg a ụbọchị, nakwa nkerisi ya ugboro abụọ. Na oké iche nke ịda mbà n'obi, na-enwe ndidi mgbe ọgwụgwọ a na-egosi na ụlọ ọgwụ na gburugburu ebe obibi, na dose nwere ike 150 mg otu ugboro na nzọụkwụ abụọ. Mgbe ahụ, ọ dị mkpa iji belata dose 75 mg kwa ụbọchị, na-anọgide na ọgwụgwọ ruo mgbe mkpuruedemede N'ihi.

The kacha allowable onunu ogwu ekwesịghị gafere 375 mg kwa ụbọchị. The ọgwụgwọ na-adabere na onye na ogo nke ọrịa. Agadi Ọnụọgụ ọgwụ ga-ndinọ na obere na obere doses. All nke ọrịa n'oge ọgwụgwọ usoro ndị n'okpuru nlekọta nke a dibịa. Ịkagbu ọgwụ inikiet inikiet ike, ị ga-eji nwayọọ nwayọọ belata dose na efu, ka ha ghara ime ka a ndọrọ ego syndrome ọgwụ ọjọọ "venlafaxine". Ntuziaka maka ojiji nwere ihe ọmụma zuru ezu banyere usoro onunu ogwu.

Mmekọrịta ndị ọzọ ọgwụ dị iche iche

The ọgwụ na-adịghị na-atụ aro na njikọ na ndị na-esonụ ọgwụ ọjọọ:

• Mao inhibitors;
• "Li";
• "Haloperidol";
• "Clozapine";
• "Cimetidine";
• "Warfarin".

Mgbe concomitantly na antidepressant, a nwaanyị kwesịrị iji pụrụ ịdabere na ụzọ nke nchedo achọghị ime. N'oge mkpụrụ na-amị n'oge ara na-machibidoro aṅụ "venlafaxine" mkpụrụ ọgwụ. Nyocha gosiri na ọgwụ nwere a ezighị ezi mmetụta na nwa ebu n'afọ na mmepe nwa. The n'ọrụ mgwa na-ebute site ná nwa na ara.

mmetụta

Ihu ọma, omume nke mmetụta na-adabere na ọgwụ dose ọgwụ na ụba uche na gị n'ụlọnga. The kasị mgbaàmà nke mmetụta na-:

• ọgbụgbọ;
• vomiting;
• Loss nke agụụ;
• akọrọ ọnụ;
• ntachi;
• ụba cholesterol n'ime ọbara index;
• arọ ọnwụ;
• nācha ọbara-ọbara nke anụ ahụ;
• amụba mgbali egosi;
• tachycardia;
• nrọ ọjọọ;
• ụra disturbances;
• tremor;
• isi ọwụwa;
• dizziness;
• na obere okwu, anaphylactic Jeremaya mere.

Tupu ọgwụgwọ dị mkpa inyocha ihe nile contraindications iji ego "venlafaxine". Nleba na-ekwu na nkà mmụta ọgwụ a obere oge, na-enyere aka ịnagide ihe mgbaàmà nke ịda mbà n'obi ma laghachi a nkịtị ụzọ nke ndụ. Ma mmetụta nke na-ezighị ezi omume na-emepe emepe ezi mgbe.

Anya mkpa inye n'okpuru ndị na-esonụ ọnọdụ:

• na-adịbeghị anya oge myocardial;
• oké obi odida;
• ụba ọbara mgbali;
• Mania;
• tachycardia;
• glaucoma;
• underweight;
• agba ọbara ọchịchọ;
• akwụkwụ na-adọ;
• ọ na-adịghị na-atụ aro mgbe ọgwụgwọ ụgbọala ugbo ala na-ebu na-arụ ọrụ ndị metụtara ihe ize ndụ.

The ahịa ọgwụ usọbọ ọgwụ. The onunu ogwu nke ọgwụ ike gbanwee na inye a dọkịta. Store na a akọrọ na-apụghị iru nke ụmụaka na nkà mmụta ọgwụ "venlafaxine". Drug analogues ike zụrụ na ihe oké ọnụ price mgbe ọ bụla ahịa ọgwụ. The kasị ewu ewu na uzo ozo na-kọwara n'okpuru ebe a.

"Dapfiks"

Ọ na-ezo aka a otu nke mgbochi depressants. Dị ka chemical mejupụtara nke ọgwụ ike ike ekewet ụdị ọ bụla nke mara ụzọ nke ịda mbà n'obi. Ọ nwere ihe abụọ ifịk enantiomer racemic ụdị. The ọgwụ bụ ugbua n'ime awa abụọ mgbe ingestion esịmde kacha ịta na plasma. Home gị n'ụlọnga na ya metabolites bụ nke nwere ike serotonin reuptake inhibitors na noradrenaline na naanị weakly inhibit reuptake nke dopamine akwara ozi. The ngwaahịa anaghị inhibit ọrụ nke Mao inhibitors. Ihe ọ pụtara anyụpụ site na akụrụ ya. An yiri utịp ke CNS ọgwụ nwere "venlafaxine". Nyocha nke ọkachamara na-egosi na ọgwụ ndị yiri nnọọ na ike dochie ọ bụla ọzọ.

Egosi na contraindications

The ọgwụ na-kenyere maka ọgwụgwọ nke ịda mbà n'obi nke dị iche iche agwa. E nwere ọnụ ọgụgụ nke contraindications, mgbe na nkà mmụta ọgwụ na-ekwesịghị iwere:

• oké umeji gbasara akụrụ odida;
• ịmụ nwa, nwa;
• lactation;
• anata a Mao inhibitor mgbagwoju;
• hypersensitivity ka a umi;
• afọ 18 afọ.

Mbadamba zubere maka onu iji. The na-atụ aro dose bụ 75 mg kwa ụbọchị, na abụọ kewara doses. Ọ bụ ihe amamihe na-aṅụ ọgwụ na n'otu oge ahụ na ụtụtụ na mgbede. Ọ bụrụ na n'ime izu abụọ na-agaghị hụrụ ruru ọgwụgwọ mmetụta, na onunu ogwu n'aka nwere ike mụbara 150 mg kwa ụbọchị site n'ike ya n'ime ugboro abụọ. Ka mkpochapu mgbaàmà nke ịda mbà n'obi na ọgwụ a na-ebelata ke a dose na-anọgide na-akwado usoro ọgwụgwọ ruo mgbe zuru ezu na mgbake. Oke allowable dose ekwesịghị gafere 375 mg kwa ụbọchị.

The ọgwụ na-atụ aro ka iweli nwayọọ nwayọọ, ka ha wee ghara ịzụlite na ọrịa mberede ndọrọ ego syndrome. Pụtara "Dapfiks" nwere ike ịkpalite arọ ọnwụ. Nke a doo ọrịa na pro ọgwụ "venlafaxine" reviews. Ifelata na-enyemaka nke ọgwụ ndị a pụrụ ịbụ ngwa ngwa. Otú ọ dị, iji ọgwụ maka nzube ahụ adịghị atụ aro.

Mmekọrịta ndị ọzọ ọgwụ ọjọọ eme ihe

Ọnụ agọ mbanye ndị na-esonụ iche iche:

• Mao inhibitors;
• "Site Li";
• "Clozapine";
• "Cimetidine";
• "Warfarin".

Ọrịa ndị na-ata ahụhụ site na-adịghị ala ala ọrịa na-enwe mgbe niile ṅụọ ọgwụ, kwesịrị ịkpọ na dọkịta gị banyere ekwe omume nke na ijikọta ọgwụ ọjọọ.

The ọgwụ na-adịghị atụ aro na-aṅụ n'oge ime. Ya mere, oge nke ọgwụgwọ bụ mkpa na-eji a pụrụ ịdabere na ụzọ nke igbochi afọ. Ị nwekwara ike na-eji n'oge ara na nkà mmụta ọgwụ "Dapfiks" dị ka ya counterpart, ọgwụ "venlafaxine". Ntuziaka maka ojiji pụtara na-agwa n'ụzọ zuru ezu banyere ndị na-egosi na contraindications maka ojiji.

mmetụta

Ihu ọma, ọgwụ adịghị eme ka mmetụta na-ọma anabata ọrịa. Ndị na-esonụ mgbaàmà nwere ike ịzụlite na ahụkebe ikpe:

• ọgbụgbọ;
• vomiting;
• dizziness;
• ntachi;
• epigastric mgbu;
• ọnwụ nke agụụ;
• arọ ọnwụ;
• nrọ ọjọọ;
• urinary njigide;
• ụra disturbances;
• chaa mmeghachi omume;
• ọbara mgbali elu, tachycardia.

Ọ bụrụ na ị nwere ihe ọ bụla nke ndị a mgbaàmà kwesịrị ozugbo-achọ ọgwụ anya. Aro nwere yiri pụtara "venlafaxine". Analogues ngwaọrụ ndị dị otú ahụ dị ka "Dapfiks" nwere ike n'ụzọ zuru ezu dochie mbụ na ọcha mgbe a obere oge na-akpata ịda mbà n'obi.

The ọgwụ na-wepụtara na a na-ere ọgwụ site ọgwụ naanị. Nọgidenụ na ngwá ọrụ na a akọrọ na ọchịchịrị ebe ọ na-agaghị enwe ike iji nweta ụmụ. Ị gaghị-ekenye ọgwụ ọrịa na oké gbasara akụrụ na hepatic insufficiency. Ọzọkwa, na agadi, na onunu ogwu kwesịrị ntakiri.

"Efektin"

Ọ na-ezo aka a ìgwè nke ọhụrụ-emana antidepressants. The chemical mejupụtara nke ngwá ọrụ a na-apụghị iji tụnyere ndị ọzọ ọgwụ ọjọọ eme ihe na-na-emeso ịda mbà n'obi. Home gị n'ụlọnga mbadamba venlafaxine na ya ozugbo metabolite atụle elu reuptake inhibitors nke serotonin na nọrepinefrini na dopamine na a nta karị. The na nkà mmụta ọgwụ nwere ike ime ka ubara nnyefe nke gboo na Central ụjọ usoro.

N'otu oge, ke afo umi na-ngwa ngwa etinye obi gị dum. The kacha mmetụta pụtara na plasma mgbe 2 n'otu. Ihu ọma, dị ka ndị metabolites ewepụtara akụrụ ọgwụ "Efektin", dị ka ọgwụ ngwaọrụ "venlafaxine". Comments banyere ihe ndị a ngwá ọrụ abụọ nwere ike nụrụ na mma.

Egosi na contraindications

Idepụta ọgwụ maka ọgwụgwọ na mgbochi nke ịda mbà n'obi nke dị iche iche etiology. Ị gaghị na-ọgwụ na ndị na-esonụ mgbe:

• adịbeghị anya myocardial infarction;
• Hypersensitivity na mmiri;
• ime;
• lactation;
• ụmụ n'okpuru afọ 18;
• ọbara mgbali elu;
• tachycardia;
• ụfụ;
• agba ọbara ọchịchọ.

Ọnụọgụ ọgwụ na ovadozu

Ná mmalite nke ọgwụgwọ usoro dose ekwesịghị gafere 75 mg mbadamba a ụbọchị. The ọgwụ a rụrụ ọnụ na ekewa abụọ doses, n'ụtụtụ ma ná mgbede. A izu gasịrị, ọ gwụla ma e nwere ihe mma, na onunu ogwu na-ụba 150 mg kwa ụbọchị. Ọ dị mkpa na-aṅụ na 75 mg ugboro abụọ n'ụbọchị. Daily norm ọgwụ ekwesịghị gafere 375 mg. Gasịrị, n'elu nnata nke oma n'ihi na belata akpata ịda mbà n'obi, na ọgwụ a ga-ebelata ka kacha nta nke oriri.

Iji nọgide na ọgwụgwọ dị mkpa iji mezue mgbake. Ịkagbu pụtara na ọ dị mkpa nke nta nke nta. ọgwụ ọjọọ, "Venlafaxine ghara" na-kenyere na otu usoro onunu ogwu. Nyocha na-egosi na ndị nọ n'ọnọdụ nwere otu kwe nkwa.

Ndị na-esonụ mgbaàmà ime na ịṅụfe ọgwụ ike ókè nke pụtara:

• dizziness;
• ọgbụgbọ;
• ẹsụhọde ọbara mgbali;
• tachycardia;
• ụfụ.

Ọ bụrụ na bụghị adọ nyere inyere onye ọrịa aka nwere ike ịnwụ. Ọ bụrụ na mgbaàmà nke ovadozu nwere na-asa si afo, enye ọṅụṅụ absorbent na jikọọ na detoxification ọgwụ.

Women mgbe afọ 50 ezi mgbe idepụta ọgwụ "Efektin", "venlafaxine". Nyocha na menopause eme ka o kwe na-aghọta na ọgwụ na ọgwụ na-enyere aka ịnagide ịda mbà n'obi nke mere megide ndabere nke mgbanwe mmiri ọgwụ. Ọ ga-iburu n'uche na ndị agadi ndị ọrịa ọgwụ ga-amịnye a belatara dose. Na-onwe ekwesighi.

Agwọ ọrịa "Efektin" bụ dakọtara na ndị na-esonụ ọgwụ:

• Mao inhibitors;
• "Cimetidine";
• "Risperidone";
• "Kafiin";
• "Diazepam".

The ọgwụ nwere ike ime ka ịkwụsị ịṅụ na nwa ọhụrụ, ya mere, ọ na-adịghị atụ aro n'oge ime na nwa ara na.

-Ekwesịghị ịga nke ọgwụ nwere ike ime ka ndị na-esonụ mmetụta:

• dizziness;
• ọgbụgbọ;
• vomiting;
• ntachi;
• afo mgbu;
• ụra disturbances;
• nrọ ọjọọ;
• arọ ọnwụ;
• Mbelata ọbara mgbali egosi;
• tachycardia;
• urinary njigide.

Nyocha nke ụgbọala "venlafaxine" na ya analogues

Ihu ọma ọgwụ ọjọọ na-ọma na-anabata. Na-emepe emepe mmetụta ọgwụ ị chọrọ iji kagbuo na idepụta symptomatic ọgwụgwọ. Tupu ọgwụ dị mkpa iji na-amụ ihe niile n'akụkụ mmetụta na ọgwụ ọjọọ nwere ike ime ka.

Ọtụtụ ndị ọkachamara na-akwado na iji ọgwụ "venlafaxine" ịda mbà n'obi. Nyocha gosiri na nkà mmụta ọgwụ na-enyere onye ọrịa laghachi kwesịrị ndụ na nke kasị nso-ekwe omume n'oge.

Kọwara ọgwụ na-adịghị na-eri ahụ. Ọgwụ ọjọọ dị na mbadamba ụdị, nke nwere ike conveniently ndinọ ọnụ. N'ime a obere oge, ị nwere ike nweta nkasi ụdị dị iche iche nke ịda mbà n'obi ma laghachi kwesịrị ndụ. Kwesịrị ịga hụ dọkịta tupu eji ọgwụ "venlafaxine". Nyocha gosiri na oghom ihe ndị ọzọ Ugboro na ikpe ma ọ bụrụ na onye ọrịa na-emekwa ụfọdụ na onwe-medicate.